- Case report
- Open Access
A reminder of the association between Clostridium septicumand colonic adenocarcinoma
© Khan and Davenport; licensee BioMed Central Ltd. 2006
- Received: 20 February 2006
- Accepted: 28 April 2006
- Published: 28 April 2006
We present the case of a patient, with previously unknown liver metastases, presenting with a liver abscess and Clostridium septicum septicaemia. C. septicum is known to be associated with both malignancy and immunosuppression and therefore in patients where this organism is isolated, efforts must be made to exclude an occult underlying malignancy or haematological disorder.
- Liver Abscess
- Liver Carcinoma
- Mild Renal Impairment
- Cyclical Neutropenia
Severe infection with Clostridium septicum in healthy humans is relatively rare. The organism used to be a well known complication of war wounds in the form of gas gangrene . C. septicum can cause other rigorous focal or disseminated infections by spontaneous invasion from the gut of compromised patients. C. septicum produces exotoxin which is responsible for rapid progression of infection. Exotoxin hydrolyses cell membranes, causes tissue necrosis by inducing occlusive microvascular thrombosis. These spontaneous forms of infection are believed to be associated with colonic malignancy (especially in the cecum) , acute leukemia or cyclical neutropenia . Unlike C perfringens, C septicum is aerotolerant and can infect normal tissues. We are reporting this recent case as a reminder of this association and to re-emphasise the importance of investigating these patients for occult malignancy.
Clostridium septicum is an anaerobic, gas forming, gram-positive bacillus. It is thought to be an intestinal commensal in man and animals. It is believed that the caecum and terminal ileum provide the most favourable environment for colonisation. The presence of mucosal barrier disruption, for example, mucosal ulceration secondary to malignancy, ischaemia or chemoradiotherapy, is thought to allow invasion into the blood stream. The gastrointestinal tract is the presumed portal of entry in the majority of cases.
Infections with this organism are rare but are associated with serious outcomes with a mortality of up to 45–70 %. It produces marked toxicity and may present as gas gangrene, myonecrosis, sepsis or liver abscesses. C. septicum is rarely able to cause liver abscesses in the absence of any underlying pathology . Most typically the underlying lesion is a metastasis, which has outgrown its blood supply and therefore provides an ideal anaerobic environment for bacterial growth. The gas produced by the organism appears to remain limited to the area of metastases and does not invade adjacent healthy tissue  so causing generalised liver enlargement. To the best of our knowledge, this organism has not been reported with primary liver carcinoma in the literature.
There is a known association between C. septicum and immunosuppression or malignancy, most commonly of colonic or haematological origin, although there are reported cases in association with choriocarcinoma  and breast carcinoma  in the literature. In one study  looking at all Clostridial infections, 11% were secondary to C. septicum, an associated malignancy was found in 50% (as compared to 11% of patients with other clostridial infections) and the remaining patients all had evidence of immunosuppression. There was 56% mortality with C. septicum as opposed to 26% with other strains. In another , 87.5% of cases were found to have malignancy, 86% of these originated in the gastrointestinal tract and the remainder were haematological.
Intravenous antibiotics, predominantly penicillin, remain the mainstay of treatment, and in some cases, surgical debridement is necessary.
Those patients found to have C. septicum should undergo an aggressive search for an underlying malignancy or haematological abnormality if they are fit for further interventions.
The author(s) declare that they have no competing interests.
- Sebald M, Hauser D: Pasteur, oxygen and the anaerobes revisited. Anaerobe. 1995, 1: 11-16. 10.1016/S1075-9964(95)80353-X.View ArticlePubMedGoogle Scholar
- Kornbluth AA, Danzig JB, Bernstein LH: Clostridium septicum infection and associated malignancy. Medicine. 1989, 68: 30-37.View ArticlePubMedGoogle Scholar
- Caya JG, Farmer SG, Ritch PS, Wollenberg NJ, Tieu TM, Oechler HW, Spivey M: Clostridial septicemia complicating the course of leukemia. Cancer. 1986, 57: 2045-2048.View ArticlePubMedGoogle Scholar
- Kolbeinsson ME, Holder WD, Aziz S: Recognition, management and prevention of Clostridium septicum abscess in immunosuppressed patients. Arch Surg. 1991, 126: 642-645.View ArticlePubMedGoogle Scholar
- Lee C-H, Hseih S-Y: Case report: Clostridium septicum infection presenting as liver abscess in a case of choriocarcinoma with liver metastasis. J Gast & Hep. 1999, 14 (12): 1227-1229. 10.1046/j.1440-1746.1999.02034.x.View ArticleGoogle Scholar
- Katlic MR, Dervac WM, Coleman WS: Clostridium septicum infection and malignancy. Ann Surg. 1981, 193 (3): 361-364.PubMed CentralView ArticlePubMedGoogle Scholar
- Larson CM, Bubrick MP, Jacobs DM, West MA: Malignancy, mortality and medicosurgical management of Clostridium septicum infection. Surgery. 1995, 118 (4): 592-598.View ArticlePubMedGoogle Scholar
- Pelfry TM, Turk RP, Peoples JB, Elliott DW: Surgical aspects of Clostridium septicum septicaemia. Arch Surg. 1984, 119 (5): 546-550.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.